ABSI - Absci Corp

2.78
-0.100   -3.597%

Share volume: 4,198,380
Last Updated: 03-27-2026
Business Services/Services – Research, Development, Testing Labs: -0.05%

PREVIOUS CLOSE
CHG
CHG%
$2.88
-0.10
-0.03%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
32%
Profitability 35%
Dept financing 22%
Liquidity 43%
Performance 30%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-5.12%
1 Month
-0.71%
3 Months
-19.42%
6 Months
-6.40%
1 Year
2.96%
2 Year
-51.06%
Key data
Stock price
$2.78
P/E Ratio 
N/A
DAY RANGE
$2.72 - $2.96
EPS 
-$0.86
52 WEEK RANGE
$2.01 - $5.23
52 WEEK CHANGE
$10.76
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
153.021 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-13-2025
BETA 
2.50
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5,309,425
AVERAGE 30 VOLUME 
$4,134,836
Company detail
CEO: Sean McClain
Region: US
Website: absci.com
Employees: 210
IPO year: 2021
Issue type: Common Stock
Market: XNAS
Industry: Business Services/Services – Research, Development, Testing Labs
Sector: Services

Absci Corporation provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Absci was founded in 2011 and is headquartered in Vancouver, Washington.

Recent news